Media

Support Of Industry Underscores Pro-Business Commitment
2014 Livestock Biotech Summit three day programming touched on issues such as engaging consumers, animal welfare, the promise of the technology.

Press Releases

Mar 6 2003
WASHINGTON, D.C. (March 6, 2003)—The Biotechnology Industry Organization (BIO) in collaboration with eight Midwestern states and the Midwestern Health...
Feb 28 2003
Washington, D.C. (February 27, 2003) - Michael Werner, vice president for bioethics at the Biotechnology Industry Organization (BIO), today issued the...
Feb 27 2003
New York (February 27, 2003) – The Biotechnology Industry Organization (BIO) and Long Island Life Sciences Initiative (LILSI) announced today the...
Feb 21 2003
WASHINGTON, D.C. (February 21, 2003) - Three groups of industry experts will hold press briefings during the Biotechnology Industry Organization’s (BIO) CEO...
Feb 14 2003
WASHINGTON, D.C. (February 14, 2003) – Today is the deadline for advance media registration for the Biotechnology Industry Organization’s (BIO) CEO &...
Feb 14 2003
WASHINGTON, D.C. (February 14, 2003) - Carl B. Feldbaum, President of the Biotechnology Industry Organization (BIO), today issued the following statement...
Feb 12 2003
WASHINGTON, D.C. (February 12, 2003) --- In recognition of biotechnology corporate excellence, the eighth annual Helix Award will be presented to three...
Feb 11 2003
WASHINGTON, D.C. (February 11, 2003)—The Biotechnology Industry Organization (BIO) today announced an array of industry experts that will discuss the future of...
Feb 5 2003
Washington, D.C. (February 5, 2003) - Michael Werner, vice president for bioethics at the Biotechnology Industry Organization (BIO), today issued the following...


Biotechnology News

October 1, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that it has secured a $31 million term loan...

October 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stemgent Inc. announced today that it has completed the sale of its stem cell reagents and services business to ReproCELL in a cash...

October 1, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class...

October 1, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will report operating results for the third quarter of 2014 after market...

October 1, 2014

WILLOW GROVE, Pa.--(BUSINESS WIRE)--New Article highlights a more Effective Method for Analyzing Sexual Assault Evidence